避孕器具市場規模、佔有率、成長分析、按產品類型、按技術、按分銷管道、按地區 - 行業預測，2024-2031 年

2022年全球避孕器具市場規模為114.1億美元，從2023年的120.3億美元成長到2031年的183.2億美元，在預測期內（2024-2031年）預計複合年成長率為5.4。

在避孕領域，預計透過旨在減少意外懷孕和降低醫療成本同時提高用戶意識的計劃來實現市場成長。各國政府和醫療保健組織正在推動「每個婦女每個兒童」、「千禧年發展目標」和「2030 年永續目標」(SDG) 等關鍵發展目標，以倡導計劃生育和避孕藥具的普及。私營和公共部門都為避孕藥具的提供做出了重大貢獻，其中私營部門主要提供避孕套和避孕藥等短效方法。例如，在亞洲，約 41% 的女性私下獲得避孕器，而 56% 的女性則依賴公共提供者。各國政府也進行大規模宣傳活動和性教育計劃，以促進青少年使用避孕藥具，並獲得世界衛生組織和疾病預防控制中心等組織的支持，以促進安全性行為。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管分析
• 專利分析
• 案例研究分析
• Start-Ups分析

依產品類型分類的避孕器具市場規模及複合年成長率（2024-2031）

• 市場概況
• 男性避孕器
• 女性避孕器
• 女性用避孕套子宮託海綿
• 避孕環
• 子宮內避孕器
• 皮下植入
• 其他

避孕器具市場規模：依技術及複合年成長率（2024-2031）

• 市場概況
• 荷爾蒙避孕藥
• 屏障避孕器

避孕器具市場規模：依通路及複合年成長率（2024-2031）

• 市場概況
• 醫院藥房
• 零售藥房
• 診所
• 線上管道
• 公共管道和非政府組織
• 其他

避孕器具市場規模及複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Bayer AG（Germany）
• Pfizer Inc.（US）
• Janssen Global Services, LLC（US）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Merck Sharp & Dohme Corp.（US）
• Mylan NV（US）
• Reckitt Benckiser Group plc.（UK）
• Veru Inc.（US）
• Medisafe Distribution Inc.（Canada）
• CooperSurgical, Inc.（US）
• Devex（US）
• Mayer Laboratories, Inc.（US）
• Allergan plc（Ireland）
• Agile Therapeutics（US）
• HLL Lifecare（India）
• Ansell Ltd（Australia）
• Mankind Pharma（India）
• TTK HealthCare（India）
• Boehringer Ingelheim International GmbH.（Germany）
• V-Care Pharma Pvt. Ltd.（India）

結論和建議

Global Contraceptive Devices Market size was valued at USD 11.41 billion in 2022 and is poised to grow from USD 12.03 billion in 2023 to USD 18.32 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

Market growth in the contraceptive sector is anticipated through programs aimed at reducing unintended pregnancies and healthcare costs while enhancing user awareness. Key initiatives such as Every Woman Every Child, Millennium Development Goals, and the 2030 Sustainable Development Goals (SDGs) are being spearheaded by governments and healthcare organizations to advocate for family planning and contraceptive utilization. Both private and public sectors significantly contribute to contraceptive provision, with the private sector predominantly supplying short-acting methods like condoms and pills. For instance, in Asia, around 41% of women source contraceptives privately, while 56% rely on public providers. Governments are also implementing extensive campaigns and sex education programs to promote contraceptive use among youth, receiving support from organizations like the WHO and CDC in fostering safe sex practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptive Devices Market Segmental Analysis

Global Contraceptive Devices Market is segmented by product type, technology, distribution channel and region. Based on product type, the market is segmented into male contraceptive devices, female contraceptive devices, female condoms, diaphragms & sponges, vaginal rings, intrauterine devices, sub-dermal implants and others. Based on technology, the market is segmented into hormonal contraceptives and barrier contraceptives. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, clinics, online channels, public channel & ngo and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contraceptive Devices Market

The Global Contraceptive Devices market is significantly driven by the introduction of highly efficient, non-hormonal intrauterine devices (IUDs). This innovative contraceptive technology presents a reliable and long-lasting option for women, combining a unique design that prioritizes safety and ease of use. The non-hormonal aspect reduces the likelihood of side effects, making it an attractive alternative for those who may be sensitive to hormonal contraception. Its effectiveness and user-friendly features cater to women's needs for convenience and dependability in birth control, thus enhancing its appeal in the market and potentially boosting overall demand for contraceptive solutions globally.

Restraints in the Global Contraceptive Devices Market

The Global Contraceptive Devices market faces certain constraints, particularly concerning the heightened risk of infections associated with the use of these devices. While contraceptive devices are designed to empower individuals in making informed reproductive health choices, the potential for infections can undermine their effectiveness and safety. The reliance on various methods, such as condoms, intrauterine devices (IUDs), and hormonal implants, is intended to provide reliable birth control and promote reproductive autonomy. However, concerns surrounding hygiene and the risks of complications can deter some users, hindering the broader acceptance and implementation of these essential tools for family planning and responsible sexual health practices.

Market Trends of the Global Contraceptive Devices Market

The Global Contraceptive Devices market is experiencing robust growth, driven by escalating rates of unwanted pregnancies and a heightened awareness of family planning methods. The rising incidence of sexually transmitted infections (STIs) and increased government funding for family planning initiatives further bolster market expansion. An array of contraceptive options including condoms, intrauterine devices, oral contraceptives, and subdermal implants, combined with growing consumer purchasing power, are notable contributors. Additionally, the surge in e-commerce, advancements in long-acting reversible contraceptives, and a trend towards innovative products align with the demand for non-hormonal and female-controlled contraceptives, thereby fueling continued market development.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis
• Case Study Analysis
• Startup Analysis

Global Contraceptive Devices Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Male Contraceptive Devices
• Female Contraceptive Devices
• Female Condoms, Diaphragms & Sponges
• Vaginal Rings
• Intrauterine Devices
• Sub-Dermal Implants
• Others

Global Contraceptive Devices Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Hormonal Contraceptives
• Barrier Contraceptives

Global Contraceptive Devices Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channel & Ngo
• Others

Global Contraceptive Devices Market Size & CAGR (2024-2031)

• North America (Product Type, Technology, Distribution Channel)
  • USA
  • Canada
• Europe (Product Type, Technology, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Global Services, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Sharp & Dohme Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Devex (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ansell Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mankind Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK HealthCare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• V-Care Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations